日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantification of Bevacizumab Activity Following Treatment of Patients With Ovarian Cancer or Glioblastoma.

贝伐珠单抗治疗卵巢癌或胶质母细胞瘤患者后的活性定量分析

Lallemand Christophe, Ferrando-Miguel Rosa, Auer Michael, Iglseder Sarah, Czech Theresa, Gaber-Wagener Anouk, Di Pauli Franziska, Deisenhammer Florian, Tovey Michael G

A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies

一种用于定量分析治疗性抗体ADCC活性的新型系统

Lallemand, Christophe; Liang, Feifei; Staub, Flore; Simansour, Maud; Vallette, Benoit; Huang, Lue; Ferrando-Miguel, Rosa; Tovey, Michael G